Elizabeth A. Meade
- Pharmacology top 0.2%
- Genetics top 5%
- Molecular Biology
- Biochemistry top 0.5%
- Pharmacology top 2%
- Co-authors
- David L. DeWittWilliam L. SmithStephen M. PrescottThomas M. McIntyreGuy A. ZimmermanMaeve O’SullivanCharles E. McCallEdgar M. Huggins
- Topics
- Inflammatory mediators and NSAID effects (11 papers)Estrogen and related hormone effects (8 papers)Pharmacogenetics and Drug Metabolism (4 papers)
- Cited by
- PharmacologyBiochemistry
- Journals
- Journal of Biological ChemistryJournal of VirologyBiochemical and Biophysical Research Communications
- Partner nations
- United StatesSwitzerland
In The Last Decade
Elizabeth A. Meade
14 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Pharmacology 1.7k
- Genetics 618
- Molecular Biology 532
- Biochemistry 505
- Pharmacology 250
Countries citing papers authored by Elizabeth A. Meade
This map shows the geographic impact of Elizabeth A. Meade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Meade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Meade more than expected).
Fields of papers citing papers by Elizabeth A. Meade
This network shows the impact of papers produced by Elizabeth A. Meade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Meade. The network helps show where Elizabeth A. Meade may publish in the future.
Co-authorship network of co-authors of Elizabeth A. Meade
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Meade. A scholar is included among the top collaborators of Elizabeth A. Meade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Meade. Elizabeth A. Meade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 3 | |
| 3 | 255 | |
| 4 | 12 | |
| 5 | 103 | |
| 6 | 136 | |
| 7 | 191 | |
| 8 | 196 | |
| 9 | Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.breakdown → | 1084 |
| 10 | Expression of the murine prostaglandin (PGH) synthase-1 and PGH synthase-2 isozymes in cos-1 cells. | 37 |
| 11 | 168 | |
| 12 | 108 | |
| 13 | Molecular basis for the inhibition of prostanoid biosynthesis by nonsteroidal anti-inflammatory agents. | 17 |
| 14 | 10 |
About Elizabeth A. Meade
Elizabeth A. Meade is a scholar working on Pharmacology, Pharmacology and Biochemistry, having authored 14 papers that have together received 2.3k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (11 papers), Estrogen and related hormone effects (8 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Pharmacology (1.7k citations), Biochemistry (505 citations) and Pharmacology (250 citations). Elizabeth A. Meade has collaborated with scholars based in United States and Switzerland. Frequent co-authors include David L. DeWitt, William L. Smith, Stephen M. Prescott, Thomas M. McIntyre, Guy A. Zimmerman, Maeve O’Sullivan, Charles E. McCall, Edgar M. Huggins, Marita R. Inglehart and L Kaiser. Their work appears in journals such as Journal of Biological Chemistry, Journal of Virology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.